Aerokast 10mg Tablets – Montelukast for Asthma Prevention & Allergic Rhinitis

Drug Class: Leukotriene Receptor Antagonist (LTRA) | Form: Oral Tablet | Prescription Status: Prescription Only (Rx)

What Is Aerokast 10mg?

Aerokast 10mg is a prescription leukotriene receptor antagonist containing Montelukast Sodium 10mg — a once-daily oral controller medication used for the long-term prevention of asthma symptoms, relief of allergic rhinitis, and prevention of exercise-induced bronchoconstriction in adults and adolescents aged 15 years and above. Unlike inhaled corticosteroids that suppress broad airway inflammation, or bronchodilators that relax airway smooth muscle, Montelukast works through a highly specific mechanism — selectively blocking leukotriene receptors, the chemical pathway that directly drives both airway bronchoconstriction and allergic nasal inflammation simultaneously.

This dual efficacy across both the lower airways (asthma) and upper airways (allergic rhinitis) in a single once-daily evening tablet makes Aerokast a uniquely practical controller medication — particularly valuable for patients whose asthma and allergic rhinitis coexist, which is the case in a significant proportion of asthmatic patients. Aerokast is a preventer medication that must be taken regularly every day regardless of whether symptoms are present — it does not provide immediate relief during an acute asthma attack and must never be used as a rescue medication.

What Is Aerokast 10mg Used For?

Aerokast 10mg is prescribed for:

• Long-term asthma prevention (دمہ کی روک تھام) — daily controller therapy to reduce the frequency and severity of asthma symptoms including wheezing, shortness of breath, chest tightness, and nocturnal awakenings — used alone in mild persistent asthma or alongside inhaled corticosteroids in moderate asthma
• Seasonal allergic rhinitis (موسمی الرجی — بہتی ناک) — relief of nasal congestion, sneezing, runny nose, and nasal itching caused by seasonal allergens such as pollen and grass
• Perennial allergic rhinitis — year-round allergic nasal symptoms triggered by persistent allergens such as house dust mites, pet dander, and mould
• Exercise-induced bronchoconstriction (EIB) — prevention of airway narrowing and breathing difficulty triggered by physical exercise in adults and adolescents — taken at least 2 hours before exercise
• Asthma with co-existing allergic rhinitis — Montelukast uniquely addresses both conditions simultaneously through the same leukotriene pathway — making it particularly appropriate when both upper and lower airway allergic disease coexist
• Aspirin-exacerbated respiratory disease — asthma worsened by Aspirin or NSAIDs, where leukotriene overproduction is a key mechanism — Montelukast specifically targets this pathway

Aerokast is a controller medication — it prevents symptoms over time with regular daily use. It is not a rescue inhaler and will not relieve an acute asthma attack. Always keep a fast-acting bronchodilator such as Salbutamol available for acute symptom relief.

How Does Aerokast 10mg Work?

Montelukast Sodium 10mg — Selective Leukotriene Receptor Antagonist: Leukotrienes are potent inflammatory chemical mediators produced by mast cells, eosinophils, and basophils — immune cells that are central to both allergic asthma and allergic rhinitis. When exposed to allergens, exercise, cold air, or other triggers, these cells release cysteinyl leukotrienes (LTC4, LTD4, LTE4) that bind to CysLT1 receptors on multiple target cells throughout the airways and nasal passages.

In the lungs, leukotriene binding to CysLT1 receptors on airway smooth muscle causes powerful bronchoconstriction — narrowing the airways and producing the wheezing and breathlessness of asthma. Simultaneously, leukotrienes increase airway mucus secretion, promote eosinophilic airway inflammation, and increase airway wall oedema — contributing to the chronic airway remodelling that underlies persistent asthma.

In the nose, leukotriene receptor activation drives nasal mucosal swelling, increased mucus production, and sensitisation of nasal nerve endings — producing the congestion, sneezing, and rhinorrhoea of allergic rhinitis.

Montelukast selectively and competitively blocks CysLT1 receptors throughout both the lower and upper airways — preventing leukotrienes from binding and triggering their downstream inflammatory effects. By blocking this single but critically important inflammatory pathway, Montelukast simultaneously reduces airway bronchoconstriction, decreases airway mucus hypersecretion, suppresses eosinophilic airway inflammation, and relieves nasal congestion and rhinorrhoea — addressing both asthma and allergic rhinitis through one targeted daily dose.

Once-Daily Evening Dosing — Why Evening? Asthma symptoms characteristically worsen at night and in the early morning hours — a pattern driven by circadian rhythms in airway inflammation and leukotriene production that peak during sleep. Taking Montelukast in the evening ensures peak plasma concentrations coincide with the nocturnal period of maximum leukotriene activity — providing optimal overnight airway protection when it is most needed.

Dosage and Administration

⚠️ Take once daily in the evening — consistency of timing is important for optimal overnight protection. Never use Aerokast to treat an acute asthma attack — always keep a fast-acting reliever inhaler available. Do not stop taking Aerokast suddenly without consulting your doctor even if symptoms improve — asthma requires ongoing controller therapy.

Important Dosing Notes:

• For exercise-induced bronchoconstriction, take one dose at least 2 hours before planned exercise — do not take an additional evening dose on the same day if already taking Aerokast daily for asthma or rhinitis
• For asthma, benefits develop progressively over the first few days to weeks of consistent daily use — do not judge effectiveness from the first few doses alone
• For seasonal allergic rhinitis, Aerokast can be started at the beginning of the allergy season and continued throughout

How to Take:

1. Swallow the tablet whole with a full glass of water
2. Take in the evening — with or without food
3. Take at the same time each evening for consistency
4. Do not skip doses — regular daily use is essential for controller benefit
5. Continue taking even on symptom-free days — the absence of symptoms reflects the medication working, not that it is no longer needed

Active Ingredients

Who Should NOT Take Aerokast 10mg?

Do not take Aerokast if you:

• Are allergic to Montelukast Sodium or any ingredient in this product
• Are experiencing an acute asthma attack — Aerokast will not provide immediate relief; use a fast-acting bronchodilator and seek medical attention
• Are under 15 years of age for the 10mg tablet — lower dose formulations (5mg chewable for 6–14 years, 4mg granules for younger children) are available for paediatric use

Always consult your doctor before use if you:

• Have phenylketonuria (PKU) — some Montelukast formulations contain phenylalanine; confirm with your pharmacist
• Are pregnant or breastfeeding — use only when benefit clearly outweighs risk as assessed by your doctor; available data on Montelukast in pregnancy is limited
• Have a history of psychiatric or neurological symptoms — see neuropsychiatric side effects below
• Are being treated for aspirin-sensitive asthma — inform your doctor; Montelukast is appropriate but requires careful monitoring

Side Effects

Common (mild):

• Headache — the most commonly reported side effect; usually mild and transient
• Abdominal pain or nausea
• Diarrhoea
• Mild upper respiratory tract infection symptoms
• Increased liver enzyme levels — usually clinically insignificant; monitoring recommended with long-term use

Neuropsychiatric Side Effects — FDA and EMA Black Box Warning: Montelukast carries a regulatory warning regarding neuropsychiatric events that have been reported in some patients:

• Agitation, aggression, or unusual behavioural changes
• Anxiety, depression, or low mood
• Sleep disturbances — abnormal dreams, insomnia, sleepwalking
• Hallucinations
• Suicidal thoughts or behaviour — rare but serious

These neuropsychiatric effects can occur in any patient but appear more commonly in children and adolescents. Inform your doctor immediately if you or your family member notices any change in mood, behaviour, or mental state after starting Aerokast. Your doctor will reassess whether Montelukast is appropriate to continue.

Serious — Stop Use and Seek Medical Attention:

• Severe allergic reaction — rash, swelling of face or throat, difficulty breathing (یہ طبی ہنگامی صورتحال ہے)
• Churg-Strauss Syndrome — very rare eosinophilic vasculitis that has been reported in asthmatic patients on Montelukast, particularly when oral corticosteroids are reduced; symptoms include worsening respiratory symptoms, rash, and peripheral eosinophilia — report to doctor immediately
• Significant liver effects — jaundice, severe fatigue, dark urine

Drug Interactions

Storage Instructions

• Store below 25°C in a cool, dry place
• Protect from moisture and direct sunlight
• Keep in original blister pack until use
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Do not use after the expiry date on the pack or carton

Frequently Asked Questions

Can Aerokast replace my inhaled corticosteroid or rescue inhaler?

No — Aerokast serves a different and complementary role to both inhaled corticosteroids and bronchodilator relievers. Inhaled corticosteroids such as Beclomethasone or Fluticasone provide broader anti-inflammatory airway protection that is more potent than Montelukast for most patients with moderate to severe persistent asthma — Aerokast does not replace them. Fast-acting bronchodilators such as Salbutamol open constricted airways immediately during acute symptoms — Aerokast has no bronchodilatory action and cannot serve as a rescue inhaler. Aerokast is a targeted controller that specifically blocks the leukotriene pathway — it works alongside, not instead of, other asthma medications. Always keep your rescue inhaler available and continue all prescribed asthma medications unless your doctor specifically advises otherwise.

I have both asthma and allergic rhinitis — is Aerokast particularly suited for me?

Yes — patients with co-existing asthma and allergic rhinitis represent the ideal clinical profile for Montelukast. Both conditions are driven significantly by the same leukotriene inflammatory pathway — meaning a single daily Aerokast tablet simultaneously addresses airway inflammation driving asthma and nasal mucosal inflammation driving rhinitis. This upper-lower airway dual benefit is unique to leukotriene receptor antagonists and is not achieved by inhaled corticosteroids, which act primarily in the lungs. Many patients find that when their allergic rhinitis is well controlled by Aerokast, their asthma also becomes easier to manage — reflecting the well-established link between upper and lower airway allergic disease.

I have heard Montelukast can cause mood changes or depression — how concerned should I be?

This is a real and important concern that was significant enough for regulators to add a black box warning to Montelukast products. Neuropsychiatric events — including mood changes, anxiety, depression, sleep disturbances, and in rare cases suicidal ideation — have been reported with Montelukast use. The risk appears to be more common in children and adolescents than in adults, and the mechanism is not fully understood. For most adult patients taking Aerokast 10mg, the clinical benefit for asthma and rhinitis control outweighs this risk — but both the patient and their family members should be aware of the warning signs. Report any change in mood, behaviour, sleep pattern, or mental state to your doctor promptly so the benefit-risk of continuing Montelukast can be reassessed for your individual situation.

How long does it take for Aerokast to work for asthma and allergic rhinitis?

The onset of benefit varies between the two indications. For allergic rhinitis, many patients notice improvement in nasal symptoms within the first 1 to 3 days of starting Aerokast. For asthma prevention, the full controller benefit develops more gradually — most patients notice progressive improvement in symptom frequency and severity over the first 2 to 4 weeks of consistent daily use as leukotriene-mediated airway inflammation is progressively suppressed. The absence of immediate dramatic effect does not mean Aerokast is not working — do not stop taking it prematurely before the full benefit has had time to develop.

Can Aerokast be used year-round or only during allergy season?

For asthma, Aerokast should be taken year-round as a continuous daily controller medication — asthma is a chronic condition that requires consistent ongoing management regardless of season. For seasonal allergic rhinitis alone, Aerokast can be used seasonally — started at the beginning of the relevant pollen season and continued throughout. For perennial allergic rhinitis triggered by year-round allergens like dust mites or pet dander, year-round use is more appropriate. Your doctor will advise on the most suitable usage pattern based on the specific combination of conditions being treated.

---

⚕️ Medical Disclaimer: This product description is for general informational purposes only and does not replace professional medical advice. Aerokast is a prescription controller medication — always use under the supervision of a qualified doctor or respiratory specialist. It does not relieve acute asthma attacks — always keep a fast-acting rescue bronchodilator available. Report any changes in mood, behaviour, or mental state to your doctor promptly.

---

Prescription Required (Rx) | Take Once Daily in the Evening | Controller — Not a Rescue Medication | Keep Rescue Inhaler Available | Report Mood or Behaviour Changes to Doctor